11:52 AM EST - Nirvana Life Sciences Inc : Announced that it has entered into an agreement to purchase Medsmart Dispensary Inc., the exclusive North American licensee for "SOSA", a patented herbal medicine designed to detoxify the human body. Nirvana will commence a formal due diligence process that reviews the clinical studies and scientific claims behind this novel product. SOSA is a patented, WHO-approved, herbal treatment for opiate addiction that has been administered to more than 30 million patients in Asia. Nirvana Life Sciences Inc
shares C.NIRV are trading unchanged at $0.19.
